Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
170.68
+5.07 (3.06%)
At close: Oct 30, 2026, 4:00 PM EDT
170.00
-0.68 (-0.40%)
After-hours: Oct 30, 2026, 7:59 PM EDT

Gilead Sciences Revenue

Gilead Sciences had revenue of $8.30B in the quarter ending September 30, 2026, with 6.83% growth. This brings the company's total for the last twelve months to $30.99B, up 6.54% year-over-year. In the year 2025, Gilead Sciences had annual revenue of $29.44B with 2.40% growth. That makes Gilead Sciences the 448th largest company in the world by revenue and 158th in the United States.

Revenue (ttm)
$30.99B
Revenue Growth
+6.54%
P/S Ratio
6.83
Revenue / Employee
$1,822,824
Employees
17,000
Market Cap
211.70B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Product Sales 28.92B 98.2%
  • Royalty, Contract and Other 527.00M 1.8%

By Geography

  • United States 20.88B 70.9%
  • Europe 5.06B 17.2%
  • Rest of World 3.50B 11.9%
Fiscal year ended Dec 31, 2025 See the full Gilead Sciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.44B689.00M2.40%
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 201922.45B322.00M1.46%
Dec 31, 201822.13B-3.98B-15.24%
Dec 31, 201726.11B-4.28B-14.09%
Dec 31, 201630.39B-2.25B-6.89%
Dec 31, 201532.64B7.75B31.13%
Dec 31, 201424.89B13.69B122.19%
Dec 31, 201311.20B1.50B15.46%
Dec 31, 20129.70B1.32B15.70%
Dec 31, 20118.39B435.97M5.48%
Dec 31, 20107.95B938.04M13.38%
Dec 31, 20097.01B1.68B31.40%
Dec 31, 20085.34B1.11B26.14%
Dec 31, 20074.23B1.20B39.78%
Dec 31, 20063.03B997.74M49.19%
Dec 31, 20052.03B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson99.34B
Merck & Co.67.38B
AbbVie64.39B
Pfizer63.70B
AstraZeneca61.37B
Novartis AG57.36B
Sanofi55.89B
Novo Nordisk50.34B
Revenue Rankings